| Cat. No. |
Product Name |
Information |
| PC-24486 |
Z8526711350
CB1R agonist
|
Z8526711350 (CB1R agonist '1350) is a potent, specific agonist of cannabinoid-1 receptor (CB1R) with Ki of 0.95 nM, is a full agonist of CB1R-mediated Gi/o signaling. |
| PC-24481 |
VIP36
CB1 agonist
|
VIP36 is a potent, selective and highly peripherally restricted Gi-biased agonist of cannabinoid receptor type 1 (CB1) with Ki of 22 nM in radioligand competition assays, exerts analgesic efficacy through peripheral CB1 receptors and shows limited analgesic tolerance. |
| PC-24424 |
BNS808
CB1R antagonist
|
BNS808 is a potent, peripherally selective cannabinoid-1 receptor (CB1R) antagonist with Ki values of 0.7 nM for both mouse and human CB1R and IC50 of 0.8 nM (hCB1R), >2000-fold selective over CB2R. |
| PC-24175 |
Rezosicone
CB1 antagonist
|
Rezosicone is a potent, selective cannabinoid CB1 receptor signalling inhibitor. |
| PC-24076 |
GW405833
CB2 agonist
|
GW405833 is a potent, selective cannabinoid receptor CB2 agonist with Ki of 3.6 nM, 1200-fold selectivity over CB1. |
| PC-23401 |
CB2 agonist 4Q3C
CB2 agonist
|
4Q3C is a selective CB2 receptor agonist, has selectivity index 10,000 more over CB1. |
| PC-23093 |
RTI-348
CB1 antagonist
|
RTI-348 is a potent, peripherally selective, orally active, and metabolically stable antagonist of cannabinoid receptor 1 (CB1) with Ki of 6.2 nM, 153-fold selective over CB2. |
| PC-22545 |
TM38837
CB1 inverse agonist
|
TM38837 is a potent, selective peripheral cannabinoid receptor 1 (CB1) inverse agonist with IC50 of 24 nM, 200-fold selective over CB2 receptor. |
| PC-22234 |
HU-308
CB2 agonist
|
HU-308 is a potent, selective cannabinoid CB2 receptor agonist with Ki of 22.7 nM in competition binding assay, does not bind to CB1 receptor. |
| PC-22233 |
HU-910
CB2 agonist
|
HU-910 is a potent, selective cannabinoid CB2 receptor agonist with Ki of 6 nM in competition binding assay, IC50 of 162 nM in cAMP assay. |
| PC-22211 |
SCH225336
CB2 inverse agonist
|
SCH225336 (SCH336) is a potent, selective cannabinoid receptor CB2 inverse agonist with Ki of 0.4 nM, >2000-fold selective over CB1 receptor. |
| PC-22188 |
SR141716
CB1 antagonist
|
Rimonabant (SR141716) is a highly potent, brain penetrated and selective central cannabinoid receptor (CB1) antagonist with Ki of 1.8 nM, no affinity for peripheral cannabinoid receptor. |
